Hematopoietic SCT in Europe: data and trends in 2011
J. Alejandro Madrigal(Royal Free London NHS Foundation Trust), Dominique Farge(Hôpital Saint-Louis), Jakob Passweg(University Hospital of Basel), Carmen Ruiz de Elvira(Felix Platter-Hospital), Christina Peters(Cancer Research Institute of the Slovak Academy of Sciences), Helen Baldomero(University Hospital of Basel), Simone Cesaro(Azienda Ospedaliera Universitaria Integrata Verona), Mohamad Mohty(Sorbonne Université), J.H. Frederik Falkenburg(Leiden University Medical Center), Andrea Velardi(University Niccolò Cusano), H. Bobby Gaspar(University College London), Rafael F. Duarte(Institut Català d'Oncologia), Anna Sureda(Institut d'Investigació Biomédica de Bellvitge), Marco Bregni(Ospedale San Giuseppe), Peter Dreger(Heidelberg University), Nicolaus Kröger(Universität Hamburg), Judith Marsh(King's College London)
Cited by 132
Related Papers
Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia
|New England Journal of Medicine|2018|5.7k
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group Report
|Biology of Blood and Marrow Transplantation|2014|5.4k
Axicabtagene Ciloleucel as Second-Line Therapy for Large B-Cell Lymphoma
|New England Journal of Medicine|2021|1.6k
Letermovir Prophylaxis for Cytomegalovirus in Hematopoietic-Cell Transplantation
|New England Journal of Medicine|2017|1.2k
Gene Therapy for Immunodeficiency Due to Adenosine Deaminase Deficiency
|New England Journal of Medicine|2009|1k